132 related articles for article (PubMed ID: 10894090)
1. Binding of mutant tissue-type plasminogen activators to human endothelial cells and their extracellular matrix.
Fukao H; Ueshima S; Okada K; Matsuo O
Life Sci; 2000; 66(25):2473-87. PubMed ID: 10894090
[TBL] [Abstract][Full Text] [Related]
2. Analysis of tissue-type plasminogen activator receptor (t-PAR) in human endothelial cells.
Fukao H; Matsuo O
Semin Thromb Hemost; 1998; 24(3):269-73. PubMed ID: 9701459
[TBL] [Abstract][Full Text] [Related]
3. Interaction of wild-type and catalytically inactive mutant forms of tissue-type plasminogen activator with human umbilical vein endothelial cell monolayers.
Ramakrishnan V; Sinicropi DV; Dere R; Darbonne WC; Bechtol KB; Baker JB
J Biol Chem; 1990 Feb; 265(5):2755-62. PubMed ID: 2105933
[TBL] [Abstract][Full Text] [Related]
4. Binding of tissue-type plasminogen activator with human endothelial cell monolayers. Characterization of the high affinity interaction with plasminogen activator inhibitor-1.
Russell ME; Quertermous T; Declerck PJ; Collen D; Haber E; Homcy CJ
J Biol Chem; 1990 Feb; 265(5):2569-75. PubMed ID: 2105930
[TBL] [Abstract][Full Text] [Related]
5. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.
Schleef RR; Podor TJ; Dunne E; Mimuro J; Loskutoff DJ
J Cell Biol; 1990 Jan; 110(1):155-63. PubMed ID: 2104856
[TBL] [Abstract][Full Text] [Related]
6. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
[TBL] [Abstract][Full Text] [Related]
7. Heparin enhances active site-dependent binding of tissue-type plasminogen activator to endothelial cells.
Rosenfeld L; Kuo A; Hirsh J; Klugherz B; Gardell SJ; Cines DB; Barnathan ES
Blood; 1992 Sep; 80(6):1486-95. PubMed ID: 1520875
[TBL] [Abstract][Full Text] [Related]
8. Analysis of binding protein for tissue-type plasminogen activator in human endothelial cells.
Fukao H; Hagiya Y; Nonaka T; Okada K; Matsuo O
Biochem Biophys Res Commun; 1992 Sep; 187(2):956-62. PubMed ID: 1326962
[TBL] [Abstract][Full Text] [Related]
9. Determinants of binding and internalization of tissue-type plasminogen activator by human vascular smooth muscle and endothelial cells.
Grobmyer SR; Kuo A; Orishimo M; Okada SS; Cines DB; Barnathan ES
J Biol Chem; 1993 Jun; 268(18):13291-300. PubMed ID: 7685759
[TBL] [Abstract][Full Text] [Related]
10. The interaction of recombinant tissue type plasminogen activator and recombinant plasminogen activator (r-PA/BM 06.022) with human endothelial cells.
Mulder M; Kohnert U; Fischer S; van Hinsbergh VW; Verheijen JH
Blood Coagul Fibrinolysis; 1997 Mar; 8(2):124-33. PubMed ID: 9518044
[TBL] [Abstract][Full Text] [Related]
11. Co-localization of urokinase and its receptor on established human umbilical vein endothelial cell.
Ueshima S; Matsumoto H; Izaki S; Mitsui Y; Fukao H; Okada K; Matsuo O
Cell Struct Funct; 1999 Apr; 24(2):71-8. PubMed ID: 10362070
[TBL] [Abstract][Full Text] [Related]
12. Binding of tissue plasminogen activator to cultured human endothelial cells.
Hajjar KA; Hamel NM; Harpel PC; Nachman RL
J Clin Invest; 1987 Dec; 80(6):1712-9. PubMed ID: 3119664
[TBL] [Abstract][Full Text] [Related]
13. The position of the structurally autonomous kringle 2 domain influences the functional features of tissue-type plasminogen activator.
Bakker AH; Rehberg EF; Marotti KR; Verheijen JH
Protein Eng; 1995 Mar; 8(3):293-300. PubMed ID: 7479691
[TBL] [Abstract][Full Text] [Related]
14. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
15. Structure and function of human tissue-type plasminogen activator (t-PA).
van Zonneveld AJ; Veerman H; MacDonald ME; van Mourik JA; Pannekoek H
J Cell Biochem; 1986; 32(3):169-78. PubMed ID: 3097031
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of tissue-type plasminogen activator (t-PA) activity by purified t-PA receptor expressed in human endothelial cells.
Fukao H; Ueshima S; Takaishi T; Okada K; Matsuo O
Biochim Biophys Acta; 1997 Mar; 1356(1):111-20. PubMed ID: 9099997
[TBL] [Abstract][Full Text] [Related]
17. Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells.
Oszajca K; Bieniasz M; Brown G; Swiatkowska M; Bartkowiak J; Szemraj J
Biochem Cell Biol; 2008 Dec; 86(6):477-86. PubMed ID: 19088796
[TBL] [Abstract][Full Text] [Related]
18. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).
Nelles L; Lijnen HR; Van Nuffelen A; Demarsin E; Collen D
Thromb Haemost; 1990 Aug; 64(1):53-60. PubMed ID: 2148847
[TBL] [Abstract][Full Text] [Related]
19. Binding of type 1 plasminogen activator inhibitor to the extracellular matrix of cultured bovine endothelial cells.
Mimuro J; Loskutoff DJ
J Biol Chem; 1989 Mar; 264(9):5058-63. PubMed ID: 2494180
[TBL] [Abstract][Full Text] [Related]
20. Different fibrinolytic potentials between human umbilical vein endothelial cells and human adult vein endothelial cells.
Rydholm H; Boström S; Eriksson E; Risberg B
Eur Surg Res; 1996; 28(5):380-7. PubMed ID: 8880128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
